Catalyst Wire Dossier Catalyst Wire Dossier

Nelfinavir mesylate

nelfinavir
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Nelfinavir mesylate, covering 2015-02-23 to 2024-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma [Phase 2]

See pricing